According to Arcus Biosciences 's latest financial reports the company's current revenue (TTM) is $0.11 B. In 2022 the company made a revenue of $0.11 B a decrease over the years 2021 revenue that were of $0.38 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.11 B | 4.79% |
2022 | $0.11 B | -70.84% |
2021 | $0.38 B | 393.93% |
2020 | $77.51 M | 416.78% |
2019 | $15 M | 79.58% |
2018 | $8.35 M | 491.15% |
2017 | $1.41 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |